Evaluating Outcomes in the Placement of Boomerang Percutaneous Device
NCT ID: NCT00732628
Last Updated: 2009-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
200 participants
OBSERVATIONAL
2008-01-31
2008-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Background:
Very few publications have evaluated this relatively novel percutaneous closure device.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Coronary Artery and Coronary Artery Bypass Graft Imaging Using a Specialized Catheter and Computed Tomography
NCT00474565
PMEG for Repair of Pararenal and Thoracoabdominal Aortic Aneurysm
NCT05195905
Study of the Penumbra Coil 400 System to Treat Aneurysm
NCT01465841
Physician-modified Endovascular Graft for Repair of Complex Thoracoabdominal and Abdominal Aortic Aneurysms
NCT04526938
Hydrogel Endovascular Aneurysm Treatment Trial
NCT01407952
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Boomerang percutaneous closure unit
patients having a Boomerang percutaneous closure device after a Neurointerventional study
Boomerang closure device
Use of percutaneous of Boomerang closure device. Follow up outcomes evaluated after the use of Boomerang closure device.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Boomerang closure device
Use of percutaneous of Boomerang closure device. Follow up outcomes evaluated after the use of Boomerang closure device.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM13883
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.